Abstract
The role of nonclinical toxicology studies in drug development pharmaceutical companies is to contribute to the selection of candidate compounds as well as to conduct risk assessments in humans through exploratory and development research, and to provide drugs with an appropriate benefit/risk balance. The researchers responsible for nonclinical toxicology studies need to perform various experiments to provide high-quality data and have the ability to interpret the data appropriately and make data-driven decision-making. In recent years, the modality of candidate compounds has diversified, requiring high scientific knowledge and expertise. Compliance with guidelines and Good Laboratory Practice (GLP), as well as experience and knowledge of regulatory science are also important for conducting toxicology studies for regulatory submission. Therefore, diverse skills, knowledge, and expertise are required for researchers in pharmaceutical companies; and making education and career development are essential. This presentation will introduce the educational program implemented in our company and share the current challenges of toxicology education in pharmaceutical companies to enhance discussions.
